Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Antidepressants Don't Work for 70% of Patients

Little better than placebos in all but the most severe cases

By Kevin Spak,  Newser Staff

Posted Jan 6, 2010 7:43 AM CST

(Newser) – Antidepressants are little better than a placebo for all but the most severe cases of depression, according to a new analysis of recent studies. “For patients with very severe depression, the medication did have a potent effect,” the study’s lead author tells WebMD. But the effects “were pretty small or nonexistent for patients with mild or moderate depression or even into the severe range.”

The review looked at six studies, which looked at two drugs: paroxetine, the active ingredient in Paxil and Seroxat—which works on the same principle as the drugs used in Zoloft and Prosac—and impramine, an older drug used in Trofranil. For about 70% of patients, neither drug will have a significant effect, the researchers concluded, noting dryly that this is “not reflected in the implicit messages present in the marketing of these medications.”

There's little difference between antidepressants and placebos, according to a new study.
There's little difference between antidepressants and placebos, according to a new study.   (Shutterstock)
« Prev« Prev | Next »Next » Slideshow
My TakeCLICK BELOW TO VOTE
9%
9%
57%
9%
13%
4%
To report an error on this story, notify our editors.
COMMENTS
Showing 3 of 8 comments
izZY
Jan 16, 2010 4:09 AM CST
its always about the money , we all knew that years ago....70% medical doctors self medicate ...
JGirl
Jan 6, 2010 7:06 AM CST
yes, and also therapy. antidepressants aren't meant to work on their own. counselling and or/therapy is a vital part of treating depression, along with proper medication and healthy lifestyle.
hybrid
Jan 6, 2010 7:02 AM CST
because they make $$$
 

NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   BuzzFeed   |   Cracked   |   Timelines   |   POPSUGAR Tech   |   Business Insider   |   HuffPost Entertainment   |   NewsOne